Literature DB >> 12875893

The blood-brain barrier choline transporter as a brain drug delivery vector.

D D Allen1, P R Lockman.   

Abstract

Choline is a ubiquitous molecule, found throughout almost every tissue in the body. Given it is a charged cation, nearly every cellular membrane has a transport mechanism to meet the intracellular and membrane need for choline. The blood-brain barrier is no exception in that a carrier-mediated transport mechanism is present to deliver choline from plasma to brain. The carrier consists of an anionic binding area that attracts positively charged quaternary ammonium groups or simple cations. Recent reports have shown this vector to be efficacious in delivering quaternary ammonium analogs of nicotine to brain. Future work is being completed to determine if other cationic or positively charged therapeutics can be effectively delivered to brain via this carrier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875893     DOI: 10.1016/s0024-3205(03)00504-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

1.  Nicotine exposure does not alter plasma to brain choline transfer.

Authors:  Paul R Lockman; Julie Gaasch; Ghia McAfee; Thomas J Abbruscato; Cornelis J Van der Schyf; David D Allen
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

Review 2.  Utility of nutraceutical products marketed for cognitive and memory enhancement.

Authors:  Graham J McDougall; Vonnette Austin-Wells; Teena Zimmerman
Journal:  J Holist Nurs       Date:  2005-12

Review 3.  Inner blood-retinal barrier transporters: role of retinal drug delivery.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

4.  Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer.

Authors:  Vinay K Venishetty; Werner J Geldenhuys; Tori B Terell-Hall; Jessica I G Griffith; Gregory R Sondag; Fayez F Safadi; Paul R Lockman
Journal:  Curr Cancer Drug Targets       Date:  2017       Impact factor: 3.428

5.  Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporter.

Authors:  Guangrong Zheng; Zhenfa Zhang; Paul R Lockman; Werner J Geldenhuys; David D Allen; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-04-24       Impact factor: 2.823

6.  Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Vamshi K Manda; Rajendar K Mittapalli; Cornelis J Van der Schyf; Peter A Crooks; Linda P Dwoskin; David D Allen; Paul R Lockman
Journal:  Bioorg Med Chem Lett       Date:  2009-12-28       Impact factor: 2.823

7.  In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

Authors:  K Freitas; S S Negus; F I Carroll; M I Damaj
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

8.  bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.

Authors:  Zhenfa Zhang; Paul R Lockman; Rajendar K Mittapalli; David D Allen; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2008-08-30       Impact factor: 2.823

Review 9.  Molecular determinants of blood-brain barrier permeation.

Authors:  Werner J Geldenhuys; Afroz S Mohammad; Chris E Adkins; Paul R Lockman
Journal:  Ther Deliv       Date:  2015-08-25

Review 10.  Acetylcholine receptors in dementia and mild cognitive impairment.

Authors:  Osama Sabri; Kai Kendziorra; Henrike Wolf; Hermann-Josef Gertz; Peter Brust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.